JP2013515747A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515747A5
JP2013515747A5 JP2012546255A JP2012546255A JP2013515747A5 JP 2013515747 A5 JP2013515747 A5 JP 2013515747A5 JP 2012546255 A JP2012546255 A JP 2012546255A JP 2012546255 A JP2012546255 A JP 2012546255A JP 2013515747 A5 JP2013515747 A5 JP 2013515747A5
Authority
JP
Japan
Prior art keywords
ndv
polypeptide
composition
antigen
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515747A (ja
JP5933451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/062209 external-priority patent/WO2011090708A2/en
Publication of JP2013515747A publication Critical patent/JP2013515747A/ja
Publication of JP2013515747A5 publication Critical patent/JP2013515747A5/ja
Application granted granted Critical
Publication of JP5933451B2 publication Critical patent/JP5933451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546255A 2009-12-28 2010-12-28 組換えｎｄｖ抗原及びその使用 Expired - Fee Related JP5933451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29029709P 2009-12-28 2009-12-28
US61/290,297 2009-12-28
PCT/US2010/062209 WO2011090708A2 (en) 2009-12-28 2010-12-28 Recombinant ndv antigen and uses thereof

Publications (3)

Publication Number Publication Date
JP2013515747A JP2013515747A (ja) 2013-05-09
JP2013515747A5 true JP2013515747A5 (enExample) 2014-01-30
JP5933451B2 JP5933451B2 (ja) 2016-06-08

Family

ID=44189168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546255A Expired - Fee Related JP5933451B2 (ja) 2009-12-28 2010-12-28 組換えｎｄｖ抗原及びその使用

Country Status (11)

Country Link
US (1) US10633667B2 (enExample)
EP (2) EP2519258B1 (enExample)
JP (1) JP5933451B2 (enExample)
KR (1) KR20120101572A (enExample)
CN (1) CN103260643A (enExample)
AR (2) AR079767A1 (enExample)
CA (1) CA2785653C (enExample)
DO (1) DOP2012000187A (enExample)
MX (1) MX351643B (enExample)
PE (1) PE20121685A1 (enExample)
WO (1) WO2011090708A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN06277A (enExample) * 2009-12-28 2015-09-25 Dsm Ip Assets Bv
EP2519636B8 (en) * 2009-12-28 2017-08-09 DSM IP Assets B.V. Production of hemagglutinin-neuraminidase protein in microalgae
WO2012153160A1 (es) * 2011-05-07 2012-11-15 Laboratorio Avi-Mex, S.A. De C.V. Vacuna recombinante contra prrs en vector viral
US9358283B2 (en) 2011-10-28 2016-06-07 The Regents Of The University Of California Diatom-based vaccines
EP2660324A1 (en) * 2012-05-02 2013-11-06 Algenics Production of secreted therapeutic antibodies in microalgae
EP2844760A1 (en) * 2012-05-02 2015-03-11 Algenics Production of secreted therapeutic antibodies in microalgae
EP2660323A1 (en) * 2012-05-02 2013-11-06 Algenics Production of secreted therapeutic antibodies in phaeodactylum tricornutum microalgae
EP2671950A1 (de) * 2012-06-06 2013-12-11 Philipps-Universität Marburg Expression und Sekretion von rekombinanten, vollständig assemblierten Proteinkomplexen durch Mikroalgen
CN104059927B (zh) * 2014-05-09 2018-01-09 中国农业科学院生物技术研究所 鸡新城疫糖蛋白病毒抗原的制备方法及其产品
CN105567715B (zh) * 2014-10-17 2021-06-29 丰益(上海)生物技术研发中心有限公司 裂殖壶菌α-微管蛋白相关序列及其应用
US10907130B2 (en) 2014-11-05 2021-02-02 Research Institute At Nationwide Children's Hospital Methods and materials for producing recombinant viruses in eukaryotic microalgae
US10196616B2 (en) * 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof
CN107099513B (zh) * 2017-06-22 2020-07-14 北京邦卓生物科技有限公司 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用
CN113652406B (zh) * 2021-09-01 2023-05-02 青岛易邦生物工程有限公司 一种鸡传染性喉气管炎重组病毒株及其应用
CN119020301A (zh) * 2024-08-14 2024-11-26 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种新城疫m1n毒株及改造方法和重组疫苗制备方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
BR8705281A (pt) 1986-01-08 1987-12-22 Rhone Poulenc Agrochimie Gene degradante de haloarilnitrila,seu uso,e celulas contendo o mesmo
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5990387A (en) 1988-06-10 1999-11-23 Pioneer Hi-Bred International, Inc. Stable transformation of plant cells
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
EP1103616A3 (en) 1989-02-24 2001-06-27 Monsanto Company Synthetic plant genes and method for preparation
US5879918A (en) 1989-05-12 1999-03-09 Pioneer Hi-Bred International, Inc. Pretreatment of microprojectiles prior to using in a particle gun
US5202422A (en) 1989-10-27 1993-04-13 The Scripps Research Institute Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use
CA2080584C (en) 1990-04-18 2000-09-05 Marc Cornelissen Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells
US5932782A (en) 1990-11-14 1999-08-03 Pioneer Hi-Bred International, Inc. Plant transformation method using agrobacterium species adhered to microprojectiles
US6309647B1 (en) 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
WO1992015672A1 (en) 1991-03-07 1992-09-17 Virogenetics Corporation Genetically engineered vaccine strain
US5863542A (en) 1991-03-07 1999-01-26 Virogenetics Corporation Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
TW261517B (enExample) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
WO1994002620A2 (en) 1992-07-27 1994-02-03 Pioneer Hi-Bred International, Inc. An improved method of agrobacterium-mediated transformation of cultured soybean cells
KR960705939A (ko) 1993-11-19 1996-11-08 제이. 그랜트 브리븐 식물의 유전자 발현을 위한 키메라 조절부위 및 유전자 카세트
EP0826063A1 (en) 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
US6020169A (en) 1995-07-20 2000-02-01 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2750866B1 (fr) 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
JP4111403B2 (ja) 1996-10-11 2008-07-02 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 免疫刺激ポリヌクレオチド／免疫調節分子複合体
US5981840A (en) 1997-01-24 1999-11-09 Pioneer Hi-Bred International, Inc. Methods for agrobacterium-mediated transformation
FR2758986B1 (fr) 1997-01-31 1999-04-30 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
DE69826124T3 (de) 1997-06-30 2007-10-11 Institut Gustave Roussy Verabreichung der nukleinsäure in den quergestreiften muskel
US7161064B2 (en) 1997-08-12 2007-01-09 North Carolina State University Method for producing stably transformed duckweed using microprojectile bombardment
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
US8003772B2 (en) * 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
NZ523912A (en) 2000-07-31 2005-03-24 Biolex Inc Expression of biologically active polypeptides in duckweed
PL207132B1 (pl) 2000-11-02 2010-11-30 Intervet Int Bv Mutant wirusa choroby Newcastle (NDV), szczepionka, zastosowanie NDV zmutowanego w NP, sposób określania zakażenia NDV u drobiu, zestaw do testu diagnostycznego
TWI324181B (en) 2001-04-16 2010-05-01 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
DE60234923D1 (de) 2001-05-30 2010-02-11 Biolex Therapeutics Inc Verwendung der wasserlinse beim hochdurchsatz-screening
BR0314088A (pt) * 2002-08-27 2005-07-19 Dow Agrosciences Llc Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas
AU2004235813B2 (en) 2003-05-05 2010-07-29 Boyce Thompson Institute For Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
NZ542933A (en) * 2003-05-05 2009-08-28 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
ATE392905T1 (de) 2003-07-24 2008-05-15 Merial Ltd Vakzin-formulierungen mit einer öl-in-wasser- emulsion
EP1789530B1 (en) * 2004-08-05 2015-10-07 Ben Gurion University of the Negev Research and Development Autority Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same
JP4796787B2 (ja) 2005-04-28 2011-10-19 富士フイルム株式会社 ラビリンチュラ類への遺伝子導入法
JP4796786B2 (ja) 2005-04-28 2011-10-19 富士フイルム株式会社 ラビリンチュラ類を形質転換可能なベクター
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US9216212B2 (en) * 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
NZ587108A (en) 2007-11-27 2013-04-26 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
EP2090648A1 (en) * 2008-02-12 2009-08-19 Institut Francais de Recherche pour l'Exploitation de la Mere(Ifremer) Production of glycosylated polypeptides in microalgae
US7794714B2 (en) * 2008-03-14 2010-09-14 The United States Of America As Represented By The Secretary Of Agriculture Newcastle disease virus monoclonal antibodies
CN102271704A (zh) 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
EP2519636B8 (en) * 2009-12-28 2017-08-09 DSM IP Assets B.V. Production of hemagglutinin-neuraminidase protein in microalgae
IN2012DN06277A (enExample) * 2009-12-28 2015-09-25 Dsm Ip Assets Bv

Similar Documents

Publication Publication Date Title
RU2012143624A (ru) Рекомбинантные вакцины против вируса " синего языка ", их применение
Bukar et al. Immunomodulatory strategies for parapoxvirus: current status and future approaches for the development of vaccines against Orf virus infection
JP5913316B2 (ja) ニューカッスル病ウイルスをベクターとするヘルペスウイルスワクチン
CN112094824B (zh) 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用
RU2011126359A (ru) Рекомбинантная вакцина от птичьего гриппа и ее применение
CN106139139A (zh) 猪瘟e2亚单位疫苗及其应用
AU2016202693B2 (en) Attenuated swine influenza vaccines and methods of making the use thereof
CN109554352B (zh) 塞尼卡谷病毒svv-zm-201801及其应用
CN102614507B (zh) 一种o型口蹄疫分子标记疫苗及其制备方法
CN103266090A (zh) Asia1型口蹄疫重组病毒及其制备方法和应用
CN110218706B (zh) 表达h7n9亚型高致病性禽流感病毒ha蛋白的重组火鸡疱疹病毒的构建与应用
RU2018122755A (ru) Слитые белки fmdv-e2 и их применение
CN109321534A (zh) 一种重组基因viii型新城疫病毒弱毒株
JP2021501757A (ja) 狂犬病ウイルスワクチン
RU2012149036A (ru) Векторы парапоксвируса, содержащие антиген вируса бешенства
CN106916832B (zh) O型口蹄疫病毒重组核酸、重组疫苗株及其制备方法和应用
CN102961743A (zh) 表达鸡毒支原体TM1蛋白的重组新城疫LaSota弱毒疫苗株
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
CN119372158B (zh) 共同表达h9亚型aiv ha基因、ibv s基因和ibdv vp2基因的重组hvt及其应用
CN113462660A (zh) 表达禽传染性支气管炎病毒s蛋白重组新城疫载体疫苗、制备方法及应用
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
CN102603898B (zh) 与i群禽腺病毒免疫相关融合蛋白及其编码基因与应用
Dadar et al. Isolation and expression of recombinant viral protein (VP2) from Iranian isolates of Infectious Pancreatic Necrosis Virus (IPNV) in Escherichia coli
WO2011061849A1 (ja) 麻疹及びニパウイルス感染症に対する２価ワクチンとして有用な組換え体麻疹ウイルス
CN104404004B (zh) 鸡新型新城疫疫苗病毒毒株rClone30‑chIL15及其应用